
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.68894
Urology
Oncology
Hybrid Bladder Tumor: Urothelial Carcinoma With Squamous Cell Differentiation, Urothelial Sarcomatoid Carcinoma, and Concurrent Primary Mucinous Adenocarcinoma With Metastasis to the Penis
Muacevic Alexander
Adler John R
Antonov Petar 1
Raycheva Gabriela 2
Ivanov Georgi 3
Ivanov Atanas 1
Uchikov Petar 4
Popov Veselin 2
Tzigarovski Georgi 1
Timev Alexandar 5
Grudeva Zhanet 2
1 Department of Urology and General Medicine, Medical University of Plovdiv, Plovdiv, BGR
2 Department of Clinical Oncology, Medical University of Plovdiv, Plovdiv, BGR
3 Department of General and Clinical Pathology, Medical University of Plovdiv, Plovdiv, BGR
4 Department of Special Surgery, Medical University of Plovdiv, Plovdiv, BGR
5 Department of Urology, Medical University of Sofia, Sofia, BGR
Petar Antonov petar.antonov@mu-plovdiv.bg
7 9 2024
9 2024
16 9 e688947 9 2024
Copyright © 2024, Antonov et al.
2024
Antonov et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/293119-hybrid-bladder-tumor-urothelial-carcinoma-with-squamous-cell-differentiation-urothelial-sarcomatoid-carcinoma-and-concurrent-primary-mucinous-adenocarcinoma-with-metastasis-to-the-penis
The most common histological variants of bladder cancer include urothelial, squamous, and adenocarcinoma. In high-grade, invasive urothelial carcinoma, divergent differentiation can be observed, including glandular, squamous, trophoblastic, and small-cell types. Urothelial sarcomatoid carcinoma is characteristic of advanced carcinomas and is considered a possible common end route for all epithelial carcinomas. Adenocarcinoma of the bladder refers exclusively to true glandular carcinomas. Hybrid tumors are extremely rare and consist of more than one tumor type within the total tumor mass. Penile metastases are extremely uncommon, and there are no reported cases of metastatic adenocarcinoma of the bladder in the literature.

local recurrence of bladder cancer
muscle-invasive bladder cancer
bladder adenocarcinoma
penile metastasis
hybrid bladder tumor
==== Body
pmcIntroduction

Bladder cancer remains the most common malignancy of the urinary tract [1]. Its typical histological variants are urothelial, squamous cell, and glandular carcinoma. Urothelial muscle-invasive carcinomas often exhibit divergent differentiation into squamous, glandular, trophoblastic, and small cell types, occurring in approximately 30% of urothelial carcinoma cases [2]. Bladder adenocarcinomas are distinct from urothelial carcinomas with glandular differentiation, characterized by the formation of pseudocysts and glandular acini without columnar epithelium and mucin formation [3]. Secondary adenocarcinomas of the bladder are more common than primary ones, necessitating a comprehensive examination and differential diagnosis for the diagnosis of primary adenocarcinoma of the bladder. Sarcomatoid urothelial carcinomas are biphasic tumors composed of epithelial and mesenchymal components and are typically considered the advanced stage in the progression of all malignant epithelial neoplasms of the bladder. Hybrid neoplasms are exceedingly rare tumors consisting of two distinct tumor units, each corresponding to a specific tumor category, with both units originating within the same topographic area. Despite a well-established blood supply, penile metastases are extremely rare [4]. There are no reports in the literature of metastatic cases to the penis originating from primary adenocarcinoma of the bladder.

Case presentation

A 70-year-old man was hospitalized at the Urology Clinic due to macroscopic hematuria. He has a history of smoking, equivalent to over 40 pack years. Physical examination revealed a 1 cm tumor on the glans penis (Figure 1). Imaging examinations, including abdominal ultrasound and computed tomography (CT), confirmed hydronephrosis of the right kidney and a large bladder tumor (Figure 2).

Figure 1 Lesion of the glans penis (blue arrow).

Figure 2 Tumor formation located in the bladder (orange arrows). A) Computed tomography of bladder; B) Ultrasound of bladder.

Penile biopsy, cystoscopy with bladder biopsy, and placement of a nephrostomy tube on the right side were performed. Cystoscopy did not reveal pathological changes in the urethra or prostate gland. A tumor was identified in the bladder, occupying most of it with numerous clots. Subsequent histopathological examination of small tissue biopsies confirmed metastasis of mucinous adenocarcinoma to the penis and high-grade urothelial carcinoma in the bladder tissue, with areas showing primary mucinous features CK7 (+) in some cells, CK20 (-), AMACR (-), p63 (-), and squamous cell differentiation. Given the diagnosis of localized but muscular-invasive bladder disease, the patient underwent radical cystectomy with pelvic lymph node dissection, urethrectomy, and penile amputation. The urinary diversion was achieved with bilateral ureterocutaneostomy. Neoadjuvant chemotherapy was not administered due to severe macroscopic hematuria necessitating urgent cystectomy. Pathological examination of bladder samples revealed areas of sarcomatoid urothelial carcinoma, urothelial carcinoma with squamous cell differentiation, and primary mucinous adenocarcinoma invading the superficial muscular layer of the bladder (pT2a) (Figure 3).

Figure 3 Hybrid bladder tumor. A) Mucinous adenocarcinoma HE x50 (inside mucinous adenocarcinoma HE x200); B) Urothelial carcinoma with squamous cell differentiation HE x50 (inside metaplasia of the urothelium HE x100); C) Urothelial carcinoma with squamous cell differentiation HE x200 (inside squamous cell differentiation PanCK x200); D) Sarcomatoid urothelial carcinoma HE x200 (inside a sarcomatoid component, vimentin x200).

The prostate gland, urethra, and lymph nodes were free of tumor infiltration, while mucinous adenocarcinoma infiltrated the corpus cavernosum of the penis (Figure 4). The patient was staged as pT2a N0 M1b.

Figure 4 Metastatic focus of mucinous adenocarcinoma in the penis, around it with peritumoral edema and areas of hemorrhage.

The early postoperative period was uneventful, but around the 15th day, a palpable mass at the surgical site and subsequent sparse bloody discharge prompted a pelvic CT scan (Figure 5A). Exploration revealed clots and a lymphocele. A follow-up CT scan (Figure 5B) indicated an increase in the mass size, leading to further surgical exploration revealing significant soft tissue formations in the pelvic region.

Figure 5 A) Local recurrence (orange arrows) - three weeks after radical cystectomy; B) Advanced local recurrence (orange arrows) - 1.5 months after radical cystectomy.

Histological examination confirmed infiltration of mucinous adenocarcinoma. The patient succumbed to uncontrollable bleeding from the wound drain and metabolic disorders due to cachexia, two months after the initial diagnosis.

Discussion

Bladder cancer ranks fourth among all malignant diseases in men, following prostate, lung, and colorectal carcinoma [1]. The hallmark clinical symptom is painless macroscopic hematuria. Urothelial carcinomas constitute more than 90% of bladder cancers, while squamous cell carcinomas account for 5%, and adenocarcinomas and other histological variants make up less than 2%. In 2022, the World Health Organization (WHO) published the fifth edition of the classification of tumors of the urothelial tract, reflecting advancements in understanding the morphological diversity of urothelial carcinomas [2]. Urothelial carcinomas frequently demonstrate divergent differentiation, where alongside typical transitional cell carcinoma, morphological features of other types are observed. The incidence of invasive urothelial carcinomas with divergent differentiation in radical cystectomy specimens is substantial, reaching 33%. Squamous cell differentiation, characterized by intercellular bridges or keratinization, is found in up to 40% of invasive urothelial carcinoma cases [5]. There are no specific markers to separate squamous cell carcinoma differentiation from pure squamous cell carcinoma of the bladder [6], so the diagnosis is based on the clinical history and lack of or the presence of a clear conventional urothelial component in histological analysis. Glandular differentiation in urothelial carcinomas is the second most common variant, occurring in 6-18% of cases [7]. True glandular differentiation is defined by glands lined with columnar epithelium and mucin production, distinguishing it from pseudo glandular changes lacking cylindrical cells and mucin production [3]. Histological analysis of our patient's biopsies indicated adenocarcinoma morphology, specifically the characteristics of true glandular tumors rather than those with divergent glandular differentiation. Adenocarcinoma of the bladder is a rare and aggressive neoplasm originating from urothelial cells, presenting with a predominantly glandular phenotype [8]. It can be primary or secondary, with secondary adenocarcinomas more common and originating from various primary sites including the colon, prostate, endometrium, cervix, breast, and lungs.

Diagnosis of primary bladder adenocarcinoma requires the exclusion of metastasis from other organs [9]. Therapeutically, adenocarcinomas of the bladder are categorized into urachal and non-urachal types, with histological subtypes including enteric, mucinous, clear cell, ring cell, hepatoid, unspecified adenocarcinoma, and mixed forms. Retrospective studies generally indicate a poorer prognosis for adenocarcinoma compared to urothelial carcinoma [10], as observed in our case due to aggressive disease progression including penile metastasis and local recurrence. Sarcomatoid urothelial carcinoma of the bladder is frequently associated with advanced disease and a dismal prognosis [11]. This subtype is characterized by the presence of both epithelial and mesenchymal components, typically high-grade spindle cell sarcoma, with vimentin used as a supportive marker. It is suggested that sarcomatoid carcinoma may represent a common end stage of epithelial bladder tumors [12]. Local recurrence after radical cystectomy commonly involves soft tissues of the pelvis or pelvic lymph nodes, attributed to incomplete tumor excision, positive surgical margins, inadequate lymph node dissection, or intraoperative tumor cell spillage [13]. Typically detected 2-3 years post-surgery [14], our patient experienced rapid and fatal local recurrence within two months of initial treatment. Imaging studies for invasive aggressive bladder carcinomas are multifaceted and include a combination of CT, MRI, PET-CT, and other methods, depending on the patient's clinical situation. The choice of appropriate investigations depends on the stage of the disease, symptoms, and the patient's overall condition, as well as the presence of local spread and metastases. Adjuvant treatment for aggressive histology types of bladder carcinoma is a multidisciplinary approach that typically includes a combination of chemotherapy, radiotherapy, and, in some cases, targeted therapy or immunotherapy, depending on the patient's individual characteristics and the stage of the disease. The decision for a specific treatment regimen should be made in consultation with an oncology team to optimize the therapeutic strategy. Despite the ample blood supply to the penis, penile metastases are rare and often indicate a poor prognosis [4]. Various mechanisms of metastasis have been proposed, including direct tumor spread, retrograde venous spread, arterial spread, lymphatic spread, and instrumental spread. The first description of penile metastasis by Eberth dates back to 1870 [15], and since then, 144 cases of penile metastasis from bladder cancer have been documented. These cases predominantly involve primary urothelial carcinoma, often with squamous cell differentiation. Adenocarcinomas that metastasize to the penis typically originate from the prostate gland or colon [16]. The hybrid carcinoma presented here represents the first documented case of metastatic adenocarcinoma in the penis. Our case is unique in that it involves a synchronous diagnosis of primary bladder adenocarcinoma and metastasis to the penis, contrasting with the metachronous nature typically observed in previously reported cases of urothelial bladder carcinoma [17].

Conclusions

Hybrid neoplasms are casuistically rare tumors consisting of two distinct tumor units, each corresponding to a specific tumor category, with both units originating within the same topographic area. Divergent morphology is frequently encountered in high-grade urothelial carcinomas. The hybrid bladder carcinoma described in this case encompasses primary adenocarcinoma, sarcomatoid urothelial carcinoma, and urothelial carcinoma with squamous cell differentiation, culminating in metastasis to the penis and aggressive local recurrence of the adenocarcinoma component.

Disclosures

Author Contributions

Human subjects: Consent was obtained or waived by all participants in this study.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Petar Antonov, Gabriela Raycheva, Georgi Ivanov, Atanas Ivanov, Georgi Tzigarovski, Zhanet Grudeva

Acquisition, analysis, or interpretation of data:  Petar Antonov, Gabriela Raycheva, Georgi Ivanov, Atanas Ivanov, Petar Uchikov, Veselin Popov, Alexandar Timev, Zhanet Grudeva

Drafting of the manuscript:  Petar Antonov, Gabriela Raycheva, Georgi Ivanov, Atanas Ivanov, Georgi Tzigarovski, Zhanet Grudeva

Critical review of the manuscript for important intellectual content:  Petar Antonov, Gabriela Raycheva, Georgi Ivanov, Atanas Ivanov, Petar Uchikov, Veselin Popov, Alexandar Timev, Zhanet Grudeva

Supervision:  Petar Antonov, Gabriela Raycheva, Georgi Ivanov, Atanas Ivanov, Veselin Popov, Georgi Tzigarovski, Zhanet Grudeva
==== Refs
References

1 Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin Bray F Laversanne M Sung H Ferlay J Siegel RL Soerjomataram I Jemal A 229 263 74 2024 38572751
2 The 2022 World Health Organization classification of tumors of the urinary system and male genital organs - part B: prostate and urinary tract tumors Eur Urol Netto GJ Amin MB Berney DM 469 482 82 2022 35965208
3 Squamous and glandular differentiation in urothelial bladder carcinomas. Histopathology, histochemistry and immunohistochemical expression of carcinoembryonic antigen Histol Histopathol López-Beltrán A Martín J García J Toro M 63 68 3 1988 https://pubmed.ncbi.nlm.nih.gov/2980209/ 2980209
4 Metastasis to the penis. Case reports and review of the literature Int Urol Nephrol Osther PJ Løntoft E 161 167 23 1991 1864714
5 Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases Hum Pathol Guo CC Gomez E Tamboli P 1448 1452 40 2009 19454359
6 Variants and new entities of bladder cancer Histopathology Lopez-Beltran A Henriques V Montironi R Cimadamore A Raspollini MR Cheng L 77 96 74 2019 30565299
7 Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection Urology Wasco MJ Daignault S Zhang Y 69 74 70 2007 17656211
8 Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases Cancer Grignon DJ Ro JY Ayala AG 2165 2172 67 1991 1706216
9 Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases Histopathology Bates AW Baithun SI 32 40 36 2000 10632749
10 Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder J Urol Rogers CG Palapattu GS Shariat SF 2048 2053 175 2006 16697800
11 Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations Hum Pathol Palsgrove DN Taheri D Springer SU 1 9 85 2019 30447301
12 Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation Am J Surg Pathol Cheng L Zhang S Alexander R 0 46 35 2011
13 Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors Urology Honma I Masumori N Sato E 744 748 64 2004 15491713
14 Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: a systematic-review and framework for adjuvant radiotherapy Cancer Treat Rev Sargos P Baumann BC Eapen L 88 97 70 2018 30125800
15 Krebsmetastasen des corpus cavernosum penis Virchows Archiv Eberth C 145 146 51 1870
16 Involvement of the penis by rectocolic adenocarcinoma. Report of a case and review of the literature Dis Colon Rectum Haddad FS Manne RK 123 129 30 1987 3803118
17 Penile metastasis from primary bladder cancer: a study of 8 cases and review of the literature Onkologie Zhu YP Yao XD Zhang HL Shen YJ Huang D Ye DW 196 199 35 2012 22488090
